Top Markets
Coin of the day
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Rank in Stocks #28720
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Share Price
$0.31608234
Market Cap
$25.07M
Change (1 day)
-2.07%
Change (1 year)
-38.81%
Country
TW
Trade MegaPro Biomedical Co., Ltd (6827)

Category

Dividend yield history for MegaPro Biomedical Co., Ltd (6827)
MegaPro Biomedical Co., Ltd (stock symbol: 6827) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for MegaPro Biomedical Co., Ltd (6827) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH